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ABSTRACT

IRON AQUISITION IN THE DENTAL PATHOGEN AGGERGATIBACTER
ACTINOMYCETEMCOMITANS
By

Porscha LaRai Jefferson

July 25, 2012
The dental pathogen A. actinomycetemcomitans, a Gram- negative organism, has
been associated with aggressive forms of periodontitis. A. actinomycetemcomitans
requires iron to grow. In the host, iron-binding proteins such as transferrin, lactoferrin,
hemoglobin, and ferritin, maintain a low free-iron concentration. Microorganisms,
however, have evolved complex systems to efficiently harvest iron.
Th iron acquisition systems encoded in the genome of A. actinomycetemcomitans
are likely tailored towards the specific survival strategies needed to survive in the oral
biofilm. The objectives of this project were to determine the growth of A.
actinomycetemcomitans in different iron sources and to examine the expression of the
various iron uptake systems encoded by this organism under these conditions.
A. actinomycetemcomtians was grown in chemically defined media (CDM) with

or without an iron chelator (dipyridyl (DIP), and supplemented with various iron forms to
determine growth.

VI

The growth of A. actinomycetemcomitans was decreased in a dose-dependent
manner when cultured in CDM without exogenous ferrous sulfate supplemented with

DIP (CDIDIP). Growth of A. actinomycetemcomitans was restored most efficiently when
CDMIDIP was supplemented with hemin, less so with ferric citrate, and ferric chloride,
and not with ferrous sulfate. Using these growth conditions,. we examined the differential
regulation

of

the

numerous

iron

uptake

actinomycetemcomitans genome.
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systems

encoded
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INTRODUCTION

Periodontal Disease

Periodontal disease is a chronic progressive disease that affects various structures
of the periodontal tissues including the alveolar bone and periodontal ligament.
Periodontal disease has been divided into two separate categories: Gingivitis and
Periodontitis. Both diseases are inflammatory conditions that are encompassed in the
term periodontal disease, however the affects of both diseases are quite different.
Gingivitis, the initial stage of periodontal disease, is an inflammation of the gingival
tissue characterized by swelling, redness, and bleeding upon probing of the gingiva (3).
Although gingivitis is reversible following proper oral hygiene, if left untreated, it can
progress into the more severe, chronic inflammatory condition, periodontitis.
Periodontitis always develops from gingivitis however not all gingivitis will progress into
periodontitis.
Periodontitis is defined as a condition in which there is an inflammatory
reaction that occurs in the periodontium resulting in the destruction of the supporting soft
tissues surrounding the teeth, loss of gingivial fibers of the periodontal ligament, and
resorption of the alveolar bone. Periodontitis has also been further categorized into mild,
moderate, and severe periodontitis based on the patients clinical attachement loss (39,40).
Mild periodontits presents with 1-2 mm of attachment loss, moderate periodontitis

presents with 3-4 mm of attachment loss, and severe periodontitis displays attachment
loss greater than 4 mm. Periodontitis is even further divided into chronic or acute forms
and generalized (presenting in greater than 30% of the oral cavity) or localized (less than
30% of the oral cavity is involved).
Due to the progressive nature of this condition, if periodontitis is left untreated,
loosening and/or tooth loss is usually the result. Due to the destructive nature of
periodontal disease, it has been a frequent interest in many research projects. It has been
concluded that periodontal disease is the clinical result of a complex interaction between
the host and plaque bacteria. Destruction of periodontal supporting tissues happens as a
response to very intricate host-parasite interactions. The net result of this host-parasite
interaction, which in an unpredictable moment, accumulate and exceed the threshold of
tissue integrity thus causing tissue destruction and ultimate bone loss.
Periodontal disease is the most prevalent of bone diseases in humans and has long
been implicated as a risk factor in impairment of oral functions and tooth loss. 10-15% of
adults that have periodontal disease have it severely enough that it results in tooth loss,
ultimately leading to mastication malfunction and ageusia. While periodontal disease is
prevalent worldwide, it has had a significant impact on the United States population (9,
18, 52). Brown et al estimate that about 21.8% of adults (22.6 million) exhibit signs of
mild periodontitis, 9.5% (9.9 million) display signs of moderate periodontitis, and about
3.1 % (about 3.2 million) exhibit signs of advanced periodontitis (9). The total amount
expended for periodontal preventive procedures as well as the treatment of periodontal
diseases in the U.S. was $14.3 billion in 1999 (9). Undoubtedly, innovative methods for
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the prevention and treatment of periodontal disease would have a major impact on
healthcare costs.
Past research has suggested periodontal disease can be complicated by certain
systemic diseases, however more recently, studies suggest that the reverse may also be
true (13, 28, 29, 32, 44, 46, 50) . Current research, however controversial, proposes that
periodontal disease has important systemic implications, and can influence other diseases
such as cardiovascular disease (28, 29, 36, 39), pulmonary disease (44, 55) diabetes (23,
32, 50), and adverse pregnancy outcomes (11, 46, 47). Thus, a better understanding of the
factors that contribute to periodontal disease can be used to develop measures to improve
not only oral health of the patient, but also overall health of individuals.
The onset and progression of periodontal disease is associated with several risk
factors, including but not limited to gender, age, socio-economic status, nutrition, stress,
genetic makeup, and tobacco smoke. Though there are several risk factors, tobacco
smoke has been considered one of the most important risk factors associated with
periodontal disease (54). It is theorized that there is a positive correlation between
increased tobacco usage in the population and increased numbers of periodontal
infections (33, 52). A dose-dependent correlation has been demonstrated between the
frequency of an individual smoker and the severity of the deteriorating periodontal health
of that individual (6). Smokers are extremely more susceptible to periodontitis, with
increased alveolar bone resorption (24), attachment loss, percentage of oral sites with
significant attachment loss (25), tooth mobility, and tooth loss (42) than non smokers.
Additionally, patients who smoke are more often refractory to treatment than nonsmokers (49). Despite conflicting data that tobacco smoke may not influence the sub-
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gingival microflora (22, to), recent data strongly indicates that tobacco-induced
susceptibility to periodontitis is correlated with populational shifts in the microbial
composition of the oral biofilm (15, 19,26). For example, Umeda et al showed that there
is an increased risk of Treponema denticola inhabiting the oral cavity of smokers (61);
while

Zambon

et

al

reported

a

higher

prevalence

of

Aggregatibacter

actinomycetemcomitans, Tannerella forsythia and Porphyromonas gingivalis in smokers
(66).
While all of these factors playa role in the progression and severity of the disease,
there is clear evidence that the inflammatory response in the periodontum is initiated
against the resident microbial biofilm within the subgingival pocket (1). It is this
inflammatory reaction caused by the host innate immune response to the bacterial
pathogen that dictates the severity and progression of the periondontal infection (5).
The oral biofilm consists of several hundred bacterial species, but periodontal
disease is often associated with a progressive succession of the predominant bacterial
species in dental plaque from Gram-positive to Gram-negative (1,4). In order for bacteria
to colonize and persist in a host, bacterial pathogens must be able to counteract the innate
and adaptive immune system of the host. Bacteria are able to evade the host immune
system by maintaining a plethora of virulence factors. Many bacteria produce numerous
virulence factors that have been well-characterized, including adherence proteins,
cytotoxic factors, biofilm polysaccharides, chemotactic inhibitor, collagenases, LPS, and
toxins to counteract the host immune system. It is these different bacterial behaviors and
the resulting immune response to these pathogens that combine to promote inflammatory
tissue destruction in periodontitis (5). The production by various proinflammatory

4

cytokines (i.e. IL-1B, IL-6, TNFu, IL-8, and RANKL) in response to specific Gramnegative bacteria within the oral cavity leads to the activation of osteoclasts (37).
Activation of the bone-resorbing osteoclasts eventually results in bone resorption and
alveolar bone loss-clinical symptoms of periodontitis (41, 45, 51).

Microbial Induction of Periodontal Disease
Dental plaque is the single most important risk factor associated with the onset
and progression of periodontal disease (1). The formation of dental plaque begins with
adsorption of early colonizing bacteria onto an acquired pellicle, a layer of salivary
proteins that is mainly composed of glycoproteins that forms shortly after a dental
cleaning or tooth eruption. Once an acquired pellicle is formed, early colonizers are able
to manipulate the environment in order for other bacteria to be able to colonize and
adhere, thus forming dental plaque. It is this dental plaque that initiates the host
inflammatory reaction (5).
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Figure 1. Anatomy of the periodontium (as reviewed by Baker, P.J. (12)).
A) In health, gingival fibers connect the gingival soft tissue to the root of the
tooth, and the alveolar bone and cementum are connected by periodontal ligament
fibers. B) In periodontal disease, subgingival infection by Gram-negative bacteria
results in soft tissue damage, producing attachment loss and deepening the sulcus
into the periodontal pocket. Alveolar bone resorption moves the bone surface
away from the tooth root (vertical bone loss) and reduces the height of the alveolar
bone crest (horizontal bone loss). Copyright permission to reproduce figure
granted by Elsevier and (5).
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As mentioned previously, bacteria are able to adhere to the acquired pellicle on
hard tissue to form a biofilm. The ability of bacteria to adhere tightly to underlying
substrata impedes the efficient removal of biofilms by physical or chemical means. In the
oral cavity, biofilms form on the surfaces of both hard and soft tissues, and the
development of the biofilm depends on interactions between both bacterial cell-surface
adhesions and host receptors and bacteria-bacteria interactions (12). Without the ability to
adhere to surfaces in the oral cavity, bacteria are swallowed with the saliva and enter the
digestive tract, where they may not survive.
The last stage of bacterial colonization in the oral cavity involves late colonizers,
whose presence is often associated with periodontal disease progression. A hallmark of
inflammatory periodontal disease is the increased subgingival colonization by several
Gram-negative species, including A. actinomycetemcomitans, Prevotella intermedia,

Campylobacter rectus, and a group of three other bacteria designated 'the red complex'
bacteria (T. den ticola, T. forsynthia, and P. gingivalis) (40). It is the bacteria previously
mentioned that are considered the late colonizers or the anaerobic bacteria that cause this
inflammatory reaction in the gingival tissues. The red complex is a group of
microorganisms that are most intimately associated with adult periodontal disease. A.

actinomycetemcomitans, another late colonizer, is associated with an aggressive form of
periodontitis primarily found in juveniles, however this bacterial speices can also be
found in chronic periodontitis as well (58).
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Aggregatibacter actinomycetemcomitans
A. actinomycetemcomitans (formerly Actinobacillus actinomycetemcomitans) is a

small, fastidious, CO 2 -requiring coccobacillus (34). It is a capnophilic, facultative
anaerobic Gram-negative bacterium that belongs to the family Pasteurellaceae (34). A.
actinomycetemcomitans was initially isolated from actinomycotic oral lesions along with
Actinomyces israelii, leading to its species name (30). A. actinomycetemcomitans was

first isolated in 1912 (38), however it was never recognized as a member of the oral
microbial environment until 1975 (35). A. actinomycetemcomitans has been associated
with several systemic infections including chronic periodontitis, but the pathogen is most
known for its strong association with localized aggressive periodontitis, an extremely
destructive form of periodontal disease that is most common in adolescents and young
adults (58). The fact that A. actinomycetemcomitans has also been recovered from
subgingival

microflora

of

periodontally

healthy

patients

suggest

that

A.

actinomycetemcomitans may also represent an opportunistic pathogen. Due to A.
actinomycetemcomitans strong association with localized aggressive periodontitis, most

studies of A. actinomycetemcomitans have focused on its role in this disease. If the
disease is left untreated, localized aggressive periodontitis results in rapid destruction of
the alveolar bone and all supporting structures ultimately causing tooth loss. The disease
specifically targets the mandibular incisors and first molars (65).
A. actinomycetemcomitans, like other bacterial pathogens, utilizes a plethora of

virulence factors to cause disease and evade the host immune response. A.
actinomycetemcomitans produces numerous virulence factors that have been well-

characterized, including adherence proteins, cytotoxic factors, biofilm polysaccharides,
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chemotactic inhibitor, collagenases, LPS, and toxins. There is also strong evidence that
leukotoxin (LtxA), a 116-kDa protein that belongs to the repeats-in-toxin (RTX) family
of pore forming toxins, expression affects disease progression (8, 31). Studies have
shown that the target of LtxA is quite specific, which is unusual among RTX toxins,
killing only polymorphonuclear leukocytes, monocytes and T -cells, all cells responsible
for the innate immune response, in humans, apes, and Old World monkeys (60). Previous
studies have also demonstrated the ability of A. actinomycetemcomitans to bind and
invade epithelial (43) and endothelial cells (56), which may be an important mechanism
for evading the host immune system and disseminating beyond the initial site of infection
(17). Furthermore, fresh clinical isolates of A. actinomycetemcomitans express fimbriae
(Figure 2), which allow them to form tenacious biofilms on a variety of solid surfaces,
such as hydroxyapatite, glass, and plastic (53). Fimbriae expression may be important in
biofilm pathogenesis in vivo, however it is not the sole determinant in biofilm formation,
as isogenic smooth strains are capable of forming biofilms (57). However fimbriae are
thought to enable A. actinomycetemcomitans to colonize the tooth surface, persist in the
oral cavity, and initiate infection in the presence of salivary flow, thus classifying them as
a virulence factor.

9

Figure 2. Characteristics of clinical isolates of A. actinomycetemcomitans
(16). A) When A. actinomycetemcomitans is initially isolated from the oral
cavity and cultured on solid medium, it grows as a 'rough' colony with a
characteristic star-like structure in the center. B) As the bacterium is
passaged in liquid broth, it loses its ability to express fimbriae due to a
spontaneous mutation in the flp promoter region, and the broth becomes
turbid with the growth of isogenic non-adherent variants. When plated on
solid medium, these variants form large, smooth colonies (16). Copyright
permission to reproduce figure granted by Society for General Microbiology
and (16).
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Necessity of Iron
Iron is the most abundant metal in nature, and as such, plays a major role in the
life processes of all organisms (62). Iron is the central atom of the heme group in
hemoglobin, which is necessary for oxygen transport in blood. Iron is also present in
myogloboin which allows oxygen to diffuse through muscle cell), cytochromes (proteins
involved in the electron transport chain), proteins involved with DNA synthesis and cell
divison. Furthermore, iron is used to help produce the connective tissues in the human
body, it is incorporated in the production of neurotransmitters, as well as playing an
integral role in the maintenance of human immune system. Due to the fact that iron plays
such a integral role in life processes it is tightly regulated. Too little iron can lead to iron
deficiency anemia and present with symptoms of constant fatigue, palor, and severe
weakness. Too much iron is known as hemochromatosis and can present as abdominal
pain, fatigue, and generalized darkening of the skin.
The paucity of free iron in mucous membranes, tissues, or body fluids acts as a
host defense mechanism against bacterial infections by creating a bacteriostatic
environment, because iron

IS

an essential nutrient for all life (22). Host iron binding

proteins such as transferrin, lactoferrin, hemoglobin, ferritin all act collectively to
maintain a low free iron concentration, thus inhibiting bacterial growth (63). As
mentioned before all organisms require iron to survive. A critical component of bacterial
virulence is the ability to obtain iron from their host. Several bacteria have evolved ironsequestering mechanisms such as the secretion of siderophores, which compete with host
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Iron

binding

molecules

for

Iron.

Previous

research

has

shown

that

A.

actinomycetemcomitans is not capable of binding transferrin (22, 64). In addition, this

dental pathogen is not known to excrete siderophores (64). However, it has been shown
that A. actinomycetemcomitans is capable of binding both lactoferrin and hemoglobin (2,
21), two iron-containing compounds that serve as iron sources for other bacteria (48).
The exact sources that A. actinomycetemcomitans utilizes in the oral cavity are not
known.
Research to date has shown that A. actinomycetemcomitans has at least 15 iron
aquistion genes encoded in its genome (54). The amount of A. actinomycetemcomitans'
genome involved in iron aquistion suggests the importance of iron availability to the
survival of this organism. With all of this capability that A. actinomycetemcomitans has
to obtain iron, there must be some discression or priority in the specific type of iron that
A. actinomycetemcomitans prefers to utilize. The iron acquisition systems encoded in the

genome of A. actinomycetemcomitans are tailored towards the specific survival strategies
needed to survive in the oral biofilm. Due to A. actinomycetemcomitans genome and the
the

fact

that

A.

actinomycetemcomitans

IS

a

faculatative

anaerobe,

A.

actinomycetemcomitans is expected to be able to utilize inorganic and organic as well as

ferric and ferrous iron sources both in planktonic culture and biofilms. The most common
iron transport systems utilized by bacteria seem to be the ferric iron transport complexes
such as ABC transporters. However other bacteria such as H.. pylori, E coli, P. ginigivalis
and V. cholera also employ ferrous iron transport through Feo (Ferrous Iron Transport)
systems. Due to relatively soluble nature of ferrous iron (0.1 M for Fe2+ cf 10/\-18 M
for Fe3+ at pH 7), it would seem that ferrous iron would be the preferred iron source for
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most bacteria (68). However only under anaerobic conditions, or low pH environments
does ferrous iron transport seem predominant. This fact lead us to believe that A.
actinomycetemcomitans is able utilize ferrous iron as well as ferric iron transport in the
oral cavity (68, 69, 70). Our hypothesis is that A. actinomycetemcomitans primarily
utilizes ferric iron and hemin as iron sources in the oral biofilm due to the nature of A.
actinomycetemcomitans genome. In this study, we investigate the planktonic growth of A.
actinomycetemcomitans in an iron-limited and iron-chelated environment as well as
analyze the ability of A. actinomycetemcomitans to grow in an iron-chelated environment
supplemented with different iron sources and investigate what particular iron aquistion
genes are being upregulated in each particular iron environment.
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Gene Name

GenelD

Definition

hmsHf

AAOO490,O
0491

hemin transport and storage

afuABC

AA00696-0
0700

iron(llI) ABC transporter

hgpA

AAOO762

hemoglobin binding protein A

fecBCDE

AA00795-0
0799

iron(llI) dicitrate transporter

hltABC
(afuABC)

AA01048-0
1051

iron (III) ABC transporter

afuABC

AA01642-0
1645

iron(llI) ABC transporter

fatBDCE

AA01824-0
1827

enterocheli n tra nsporter

ftnAB

AA02120,O
2121

nonheme ferritin

hemU, fecD

AA02144,O
2145

iron(lII) ABC transporter

sidABCD

AA02151-0
2154

ferric enterobactin transporter

tbpA

AA02201

transferrin-bind ing protein

fecS

AA02380

ferric hydroxamate (chelatin) periplasmic-binding
protein

fur

AA02516

Fur, ferric uptake regulator

AfeABCD

AA02549-0
2552

iron (chelated) ABC transporter

hasR

AA02782

Outer membrane hemophore receptor

Table 1. Iron Uptake Operons in A. actinomycetemcomitans. Iron acquisition operons
encoded in A. actinomycetemcomitans genome (54). There is a redundancy of ferric iron
transporters (ABC transporters), hemin and hemoglobin transporters. A.
actinomycetemcomitans even seems to be able to utilize sideophore like molecules

secreted from other bacteria through utilization of it's enterochelin transport system.
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CHAPTER TWO:
MATERIALS AND METHODS

Bacterial strains and culture conditions. A. actinomycetemcomitans bacterial
strain

employed

in

this

study

was

A.

actiomycetemcomitans

652.

A.

actinomycetemcomitans 652 is an afimbriated, smooth colony morphotype strain and was

grown at 3rC under microaerophilic conditions in Chemically Defined Media (CDM;
Sigma-Aldrich, St. Louis, MO) and CDM supplemented with 150 uM of dipyridyl (DIP;
Sigma-Aldrich, St. Louis, MO) per liter. Ferric Chloride, Ferric Citrate, Ferrous Sulfate,
Hemin (Sigma-Aldrich, St. Louis, MO) were added to CDM with DIP at a 250 uM
concentration per liter.
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Table 2. Primers* used in this study.

0\

Primers

Primer Sequence (5' - 3')

Target Gene

Size (kbp)

5'00696
3' 0696
5' 00795
3' 00795
5' 5S rRNA
3' 5S rRNA
5' 01642
3' 01642
5' AA02120
3' AA02120
5' AA00762
3' AA00762

CGGATTACTCGCCTCACAAGCG
CCTTTGGTTTTTGCCGGATCGC
GCGCAGAAAATCGGTGATGTCGTGG
GCGATACTTTCCTGACGATAGTGTGC
GCGGGGATCCTGGCGGTGACCTACT
GCGATCTAGACCACCTGAAACCATACC
CGCAGGCGGATTTTTGGTATGGCG
CCGGCAGTTGAACCTCGCCTTTGTA
GCAAGGTTATGAAGGTGCTGCGGC
GCAGTGCCGCTTTTGCCAAGAAGTTTA
CCATGGAATTGAGACAACAAGCAACGTTAG
TCTAGATAGTCCAATTCCTGCGGTAAA

afuA 00696
afuA 00696
fecB 00795
fecB 00795
5S-2-rRNA
5S-2-rRNA
afuA 01642
afuA 01642

0.318
0.318
0.317
0.317
0.089
0.089
0.191
0.191
0.351
0.351
0.263
0.263

ftnA/rsgA 02120

ftnAlrsgA 02120
hgpA AA00762
hgpA AA00762

Achievement of an Iron Limited Environment. A. actinomycetemcomitans was
grown in a chemically defined media (CDM) in order to regulate the amount and type of
iron that the bacteria could use for growth. A. actinomycetemcomitans was grown in
CDM that contained FeS04 (CDM regular), and was then passaged into CDM that lacked
an iron source (FeS04), creating an iron limited environment.

Chemically Defined Media (COM)
Amino Acids

lL of 20x (g)

L-Glutamic Acid HCI

27.2 mM

Glycine

26.6 mM

L-Threonine

16.79 mM

L-Serine

19.03 mM

L-Lysine HCI

10.95 mM

L-Arginine HCI

11.49 mM

L-Histidine HCI H2O

14.09 mM

L-Glutamine

8.38 mM

L-Asparagine H2O

15.12 mM

L-Proline

13.23 mM

L-Asparatic Acid

15.03 mM

L-Ornithine HCI

2.37 mM

L-H ydoxyproline

3.05 mM
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Amino acids (Hydrophobic)

lL of 20x (g)

L-Alanine

22.45 mM

D-Alanine

22.45 mM

L-Leuicine

15.25 mM

L-Valine

17.07 mM

L-Tryptophan

9.79 mM

L-Methionine

13.40 mM

L-Isoleucine

15.25 mM

L-Phenylalanine

12.11 mM

L-Tyrosine

2.21 mM

L- Cystine

416.2

~M

PurineslPyrimidines

lL of 20x (g)

Adenine

1.85 mM

Guanine

1.32 mM

Cytosine HCl

2.43 mM

Thymine

1.59 mM

Xanthine

1.31 mM

Hypoxanthine

1.47 mM

Uracil

1.78 mM
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Inorganic Salts

1L of 20x (g)

MnS04

830.8 11M

NaCI

34.2 mM

K2HP04

22.9mM

KH2P04

146.9 mM

KN03

19.78 mM

Inorganic Salts

lL of 20X (g)

KI

12.05 11M

CuS045H20

5.206 11M

Boric Acid

161.7 11M

ZnS047H20

56.8 11M

Sodium

48.6 11M

molybdate

VitaminslFactors

1L of 1000x (g)

Choline chloride

358.1 mM

Beta-alanine

112.2 mM

Pyridoxal

4.04mM

Pyridoxine HCI

5.91 mM

Pyridoxamine diHCI

4.15 mM
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Spermidine HC}

6.88 mM

Nicotinic acid

8.12 mM

Nicotinaminde

8.l9 mM

Calcium pantothenate

4.56 mM

Spermine tetraHC}

2.87 mM

Thiamine HC}

3.32 mM

Myo-Inositol

55.5 mM

Nicotinamide adenine

1.51 mM

dinucleotide
p- Aminobenzoic acid

729.2 11M

Vitamin B12

7.38 11M

lLOf20~

23.8mM~

NaHC03

lLOf20~

1O.7mM~

L- Cysteine HC}

lLOflX(~

28.4IlM~

MgS047H20

20

-----~~-----~

lL of IX (g)
FeS047H20

17.9 mM

lL of Ix (mg)
CaC122H20

680.2 11M

lL of Ix
Pimelic acid

624.2 nM

0- Biotin

409.3 nM

DL-6,8-thioctic

484.6 nM

Folic acid

2.265 11M

lL of IX (mg)
Riboflavin

2.66 11M

Table 6. A. actinomycetemcomitans Chemically Defined Media. All chemicals used
were from Sigma-Aldrich, St. Louis, MO.
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Achievement of an Iron

Chelatt~d

Environment. A.

Actinomycetemcomitans growth was achieved by passaging the bacteria in an iron limited

environment (a media in which no exogenous iron source was added) and an iron
chelated environment (a media in which a chelator was added). On Day 1, A.
actinomycetemcomitans strain 652 was inoculated into regular CDM from a frozen stock.

This culture was incubated at 37°C overnight under microaerophilic conditions. On Day
2, the bacteria from the overnight culture of regular CDM was inoculated into CDM with
no iron plus 100 uM, 150 uM or 200 uM of dipyridyl (DIP) to achieve a 1st passage in an
iron chelated environment. This 1st passage was incubated at 37°C overnight under
microaerophilic conditions. On Day 3, the bacteria from the overnight culture of CDM no
iron 1st passage plus 100 uM, 150 uM, or 200 uM of DIP was inoculated into fresh media
of CDM no iron plus 100 uM, 150 uM, or 200 uM of DIP to achieve a 2nd passage in an
iron chelated environment. CDM no iron is an iron-limited environment. CDM no iron
supplemented with DIP (iron chelator) is an iron-chelated environment. Growth of A.
actinomycetemcomitans was accessed by measuring optical densities of the bacteria at

600 nM utilizing spectrophotometer. Figure 3 shows how this was accomplished.
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DAY 1
Stock

X1arCDM

DAY 2

Regular COM
1st passage
~nLimited
/
~OM

DAY 3

1st passage
Iron Limited
CDM

nd

2 passage
Iron Limited
CDM

Figure 3: Achievement of an iron limited and iron chelated environment.
Diagram shows how A. actinomycetemcomitans was passaged in order to achieve an iron
limited environment. The same mechanism was utilized in order to obtain an iron
chelated environment except in an iron chelated environment an iron chelator, dypridyl
(DIP) , was added to the CDM No Iron at 100 uM, 150 uM, and 200 uM concentrations
respectively.
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RNA Isolation. Overnight cultures of the appropriate A. actinomycetemcomitans

incubated at 37°C until the mid-exponential growth phase (O.D. of .08 for

lSI

passage

CDM No Iron with 150 uM DIP and .028 for 2nd passage CDM No Iron with 150 uM
DIP) for RNA isolation. Total RNA was isolated from A. actinomycetemcomitans cells
using the 5 Prime PerfectPure RNA Cell & Tissue kit (5 Prime Inc., Gaithersburg, MD)
according to the manufacturer's instructions. To ensure that the samples were free of
contaminating genomic DNA, the RNA preparation was digested with RQ RNase-free
DNase I (Promega Corporation, Madison, WI). The concentration and purity of each
RNA sample were measured via spectrophotometry (ND-lOOO Spectrophotometer,
NanoDrop Technologies, Inc, Wilmington, DE) and was also assessed by gel
electrophoresis. Samples were checked for contamination of genomic DNA by real-time
PCR using A. actinomycetemcomitans 5s rRNA primers (Table 2) RNA samples were
considered free of significant genomic DNA if no amplification product was detected by
real-time PCR after at least 30 cycles of amplification. RNA that was not immediately
utilized for a reverse-transcription reaction was aliquoted into 1.5 ml Eppendorf tubes
and stored at -80 C until future use.
D
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cDNA synthesis and qPCR for iron acquisition gene expression. First-strand
cDNA was prepared by using SuperScript III Reverse Transcriptase (Invitrogen,
Carlsbad, CA) according to the manufacturer's instructions. Quantitative PCR (qPCR)
was performed with the Smart Cycler system (Cepheid, Sunnyvale, CA) in a final
reaction volume of 25 III that contained 100 ng of cDNA, appropriate iron acquisition
primers (5' Induction and 3' Induction; -71 !AM final concentration), and Ix FastStart
SYBER Green Master (Roche, Indianapolis, IN). The amplification conditions for qPCRs
were as follows: denaturation at 95°C for 15 seconds, annealing at 55°C for 30 seconds,
and elongation at 72°C for 30 seconds for 35 cycles. The threshold cycle for each qPCR
was determined from a second derivative plot of total fluorescence as a function of cycle
number by using the software package supplied with the Smart Cycler system. All genespecific threshold values were normalized against threshold values from primers specific
for the A. aetinomyeetemeomitans 5S rRNA gene (-60 !AM final concentration). qPCR
reactions were carried out in triplicate with consistent results. Each qPCR end-point
amplification product was visualized by electrophoresis on 2% agarose gels. Primers
utilized in this study included aJuA 1642 (iron III ABC transporter), aJuA 0696
(periplasmic iron-compund binding protein), hgpA 0696 (hemoglobin binding protein A),
JeeR 0795 (iron III dicitrate-binding protein), andJtnA 2120 (nonheme ferritin) (54).
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CHAPTER THREE: EXPRESSION OF IRON ACQUISTION GENES

Introduction:

Dental plaque forms on surfaces of teeth and is composed of a dynamic micriobial
community. As this microbial community matures, there is an increase in gram negative
bacteria and decrease in gram positive bacteria. As gram negative bacteria proliferate in
the oral biofilm, the host immune system reacts to the microbes, and eventually leads to
periodontal disease. A. actinomycetemcomitans, is a gram negative coccibacillus, that is
associated with the aggressive forms of periodontal disease. However in order for
bacteria such as A. actinomycetemcomitans, to proliferate inside a human a host, iron is
needed. Iron is an essential element needed for growth and normal metabolic functions in
all organisms. Because the human host regulates iron, thus keeping a bacteriostatic
environment, bacteria must overcome this iron sequesteration by encoding in its genome
iron acquisition systems, in order to obtain iron from the host environment so that the
bacteria may thrive and proliferate. Research to date has shown that A.
actinomycetemcomitans has at least 15 iron aquistion genes encoded in its genome. The

iron acquisition systems encoded in the genome of A. actinomycetemcomitans are tailored
towards the specific survival strategies needed to survive in the oral biofilm. Due to all of
the capability that A. actinomycetemcomitans has to obtain iron, there must be some
dicression or priority in what type of iron A. actinomycetemcomitans prefers to utilize for
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growth. Due to the redundancy of ferric iron transporters in A. actinomycetemcomitans
geneome and the major iron sources that A. actinomycetemcomitans will encounter to in
the oral cavity lead us to our hypothesis that A. actinomycetemcomitans primarily utilizes
ferric iron, obtained from iron chelators or host proteins, and hemic as iron sources in the
oral cavity.

Results:
A. actinomycetemcomitans is capable of growing in an iron-limited

environment. In order for us to test A. actinomycetemcomitans' ability to grow in an
environment that lacked an iron source, A. actinomycetemcomitans was first grown in an
iron rich media (CDM regular) overnight in an incubator at 37C. One millliliter of
overnight planktonic cultures of A. actinomycetemcomitans strain 652 grown in CDM
regular was inoculated into fresh CDM 19 mL. Growth was analyzed for 12 hours by
measuring the Optical Density at 600 nm every hour. The first passage with no iron
culture

was

achieved

by

inoculating

from

an

overnight

culture

of

A.

actinomycetemcomitans grown in CDM regular into fresh CDM with no added iron

source (CDM No Iron). The second passage CDM No Iron culture was achieved by
inoculating from an overnight culture of A. actinomycetemcomitans grown in the first
passage of CDM No Iron. The third passage CDM No Iron culture was achieved by
inoculating from an overnight culture of A. actinomycetemcomitans grown in the second
passage of CDM No Iron. Results shown in Figure 4 are averages of O.D. ± standard
deviations.
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Growth curve of 652 in COM Regular and 1st, 2nd, and 3rd Passage No
Iron COM

-+- COM Regular

0.4 + - - - - - - - - - - - - - - - - - - - : : : : ;.t----

----- 151 Passage No Iron COM

~

o

o

2nd Passage No Iron COM

0.2 + - - - - --llf-xS.f -- - - - - - - - - - 3rd Passage No Iron COM

o ~~--.---,---.----,----,

o

5

15

10

20

25

Time (hour)

Figure 4.

Growth of A.

actinomycetemcomitans in an iron-limited

environment. Growth of A. actinomycetemcomitans measured by spectrometery O.D.
600 nm. Growth was measured in triplicates, results of growth were averages ± standard
deviations.

Results showed that A. actinomycetemcomitans was able to grow in an lion
limited

environment.

Growth

occurred

similarily

10

all

3

passages

of A.

actinomycetemcomitans without an iron source. These results lead us to a couple of
conclusions, either A. actinomycetemcomitans was capable of growing very well in an
iron limited environment due to large internal iron storage system that lasted the bacteria
well into the third passage or there were trace amounts of iron in media CDM No Iron,
even though no exogenous iron source was added to the media. This lead us to to our
second experiement of obtaining an iron-chelated environment.
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An iron-chelated environment reduces the growth of A.
actinomycetemcomitans. Passages in an iron chelated environment were achieved as
described above in Figure 4. However, the growth of A. actinomycetemcomitans was
analyzed in an iron-chelated enivornment at different concentrations of dypyridyl (DIP).
Growth was analyzed for 12 hours by measuring the Optical Density at 600 nm every
hour, as above. Figure 5a. DIP was added to the 151 and 2nd passages at 100 ~M. Figure
5b. DIP was added to the 151 and 2nd passages at 150~M. and Figure 5c. DIP was added to
the 151 and 2nd passages at 200 ~M. Results are averages O.D. at 600 nm ± standard
deviations.
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Overlay of 652 Growth in Regular CDM and
1st and 2nd Passages In No Iron CDM with
100 uM DIP
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Figure Sa. Achievement of an Iron Chelated Environment with 100 uM DIP.
Growth of A. actinomycetemcomitans measured by spectrometery O.D. 600 nm. Growth
was measured in triplicates, results of growth were averages ± standard deviations.
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Overlay of 652 Growth in Regular CDM and 1st and 2nd
Passages in No Iron CDM with 150 uM DIP
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Figure 5b. Achievement of an Iron Chelated Environment with 150 uM DIP.
Growth of A. actinomycetemcomitans measured by spectrometery O.D. 600 nm. Growth
was measured in triplicates, results of growth were averages ± standard deviations.
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Overlay Of 652 Growth in Regular CDM and 1st and
2nd Passages In No Iron CDM with 200 uM DIP
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Figure Sc. Achievement of an Iron Chelated Environment with 200 oM DIP.
Growth of A. actinomycetemcomitans measured by spectrometery O.D. 600 nm. Growth
was measured in triplicates, results of growth were averages ± standard deviations.

Results from these growth analyses displayed that an iron-chelated environment
reduces the growth of A. actinomycetemcomitans. It also proved that A.

actinomycetemcomitans has an internal iron storage system that allows growth in an iron
chelated environment well into the 151 passage. However by the 2nd passage of A.

actinomycetemcomitans in an iron chelated environment the internal iron storage system
had been depleted and A. actinomycetemcomitans growth was drastically reduced. It also
proved that there were trace elements of iron in the No Iron CDM media that A.

actinomycetemcomitans was able to utilize for growth. Now that an environment was
created in which A. actinomycetemcomitans was depleted of all sources, we then decided
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to add different sources of iron in order to see what types of iron that A.
actinomycetemcomitans preferred to utilize for growth.

Growth of A. actinomycetemcomitans utilizing different iron sources. To
determine A. actinomycetemcomitans ' ability to utilize iron sources for growth, the

l SI

passage CDM No Iron with 150 !!M DIP was inoculated into fresh CDM No Iron with
150 !!M DIP medium supplemented with 250 !!M of hemin , ferric chloride, ferric citrate,
or ferrous sulfate. To prevent ferrous sulfate from oxidizing to ferric sulfate, the growth
was analyzed under anaerobic conditions. The 1SI passage was achieved as in Figure 3.
Growth was analyzed for 12 hours by measuring the Optical Density at 600 nm every
hour. Results are averages of O.D. at 600 nm ± standard deviations.
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Overlay of 652 Growth in Regular COM and 1st Passage with No Iron with 150 uM with DIP
and 2nd Passages in Ir on Suppl emented Environments
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Figure 6. Growth of A. actinomycetemcomitans utilizing different iron sources
with 150 uM DIP and 250 uM of appropriate iron sources. Growth of A.
actinomycetemcomitans measured by spectrometery O.D. 600 run. Growth was measured
in triplicates, results of growth were averages ± standard deviations .

Hemin, Ferric Chloride, and Ferric Citrate are iron sources that A.

actinomycetemcomitns is capable of utilizing for growth. Growth of A.
actinomycetemcomitans in ferrous sulfate was similar to the amount of growth that was
witnessed in the 2 nd passage in an iron chelated environment leading us to the the
conclusion that A. actinomycetemcomitans appears to not to be able to utilize ferrous
sulfate as effectively for growth. Now that A. actinomycetemcomitans growth was
analyzed under different iron conditions, we wanted to see what particular iron genes
were up regulated or down regulated during these various iron conditons.
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Expression of iron-uptake genes under an iron-chelated environment.
Cultures utilized in this experiment were achieved as described in Figure 2. RNA was
extracted mid exponential phase (O.D. of .08 for the first passage in CDM no iron and
O.D. of .025 for the second passage in CDM no iron). RNA was isolated and cDNA was
synthesized as described in the previous methods. Real-time PCR was performed using
primers specific for iron genes. Iron genes utilized in this study were chosen based on the
genes association with qorum sensing, due to the fact that previous research has shown
that iron acquisition in A. actinomycetemcomitans is regulated by qorum sensing (72).
Expression of genes are normalized to

1st

passage expression. Results are averages of

Delta T ± standard deviations. Delta T was calculated by subtracting the cycle threshold
(Ct) determined for the each particular iron gene reaction from the Ct of the 5s rRNA
control.

Table 4a. afuA 1642 (iron (III) ABC transporter

2nd Passage in

delta T

delta (delta T)

Fold Change

9.52 ± 1.008

0.0013 ± 0.8 E-3

0.134 ± 3.350

6.63 ± 0.001

0.010 ± 0.7 E-3

1

CDM No Iron with
150 uM DiP
1st Passage in CDM
No Iron with 150
uMDIP
delta T was calculated by subtracting the cycle threshold (Ct) determined for the afuA

01642 reaction from the Ct of the 5s rRNA control. P value
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=0.031

Table 4b. afuA 0696 (periplasmic iron-compound-binding protein)

2nd Passage in

delta T

delta (delta T)

Fold Change

13.68 ± 0.601

7.62E-5 ± 0.03 E-3

9.52 ± .081

15.87 ± 0.467

8 E-6 ± 0.002 E-3

1

CDM No Iron with
150 uM DIP
1st Passage in CDM
No Iron with 150
uMDIP
delta T was calculated by subtracting the cycle threshold (Ct) determined for the afuA
0696 reaction from the Ct of the 5s rRNA control. P value

=0.0150

Table 4c. hgpA 0762 (hemoglobin binding protein A)

2na Passage in

delta T

delta (delta T)

Fold Change

9.133 ± 1.100

0.002 ± .001

.319 ± .241

7.486 ± 0.962

0.006 ± .004

1

CDM No Iron with
150 uM DIP
1st Passage in CDM
No Iron with 150
uMDIP
delta T was calculated by subtracting the cycle threshold (Ct) determined for the hgpA
0762 reaction from the Ct of the 5s rRNA control. P value
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=0.0978

Table 4d. feeB 0795 (iron(III) dicitrate-binding protein

20d Passage in

delta T

delta (delta T)

Fold Change

2.06 ± .064

0.240 ± .011

2.02 ± .007

3.076 ± 0.050

0.119 ± .004

1

CDM No Iron with
150uMDIP
1st Passage in CDM
No Iron with 150
uMDIP
delta T was calculated by subtracting the cycle threshold (Ct) determined for the feeB
0795 reaction from the Ct of the 5s rRNA control. P value

=0.0003

Table 4e. ftnA 2120 (nonheme ferritin)

20d Passage in

delta T

delta (delta T)

Fold Change

8.009 ± .003

0.004 ± 0.004 E-3

.809 ± 0.286

7.704 ± .424

0.005 ± .001

1

CDM No Iron with
150 uM DIP
1st Passage in CDM
No Iron with 150
uMDIP
delta T was calculated by subtracting the cycle threshold (Ct) determined for the feeB
0795

reaction from

the

Ct of the

5s
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rRNA

control.

P

value

=

0.0816

Discussion:
Target genes utilized in this study were chosen due to the fact that previous
research has shown that iron acquisition in A. actinomycetemcomitans are regulated by
qorum sensing (58). The target genes in this study were associated with quorum sensing.
Results showed that in an iron chelated environment, iron uptake genes of A.

actinomycetemcomitans are differentially regulated. Using the 1sl passage as a starting
point presented as a potential limitation. CDM regular, media containing an iron source,
should have been baseline and as we started to starve the bacteria we could have
witnessed differential regulation in gene expression. Real time PCR results were
normalized to the

lSI.

AfuA 1642, an iron III ABC transporter, was ultimately turned

down during the second passage in CDM No Iron with 150 uM DIP. AfuA 0696 showed
an up regulation of the gene during the 2nd passage in CDM No Iron with 150 uM DIP.
This was a very interesting result. AfuA 1642 showed down regulation during the 2nd
passage and AfuA 0696 showed an up regulation during the 2nd passage. This suggest that
there may be some distinction between these two ferric iron transporters. It may be
possible that under very limiting iron conditions that A. actinomycetemcomitans is
upregulating ferric iron transport that may be specific for iron coming from a particular
source and the other ABC transporter may be down regulated because it is intended to
transport iron obtained from a different source .. While cells are starving, there seems to
be an upregulation of afuA 0696 andfecB 0795, an iron (III) ABC transporter, and a iron
(III) dicitrate binding protein (scavenging system) respectively. The gene regulation of

ftnA 2120 essentially stayed the same in the first and the second passage. This makes
sense thatftnA 2120 is not being regulated at all considering it is essentially an iron
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storage molecule. There was down regulation of the hemoglobin binding protein, hgpA
0762 and afuA 0696. What is interesting is that there are three different afuA annotated

gene clusters in A. actinomycetemcomitans, and all three have different sequences. This
may suggest that these genes may differentially expressed, may have different functions,
and may be expressed under different conditions.
Due to the fact that A. actinomycetemcomitans possess a wide variety of potential
mechanisms to obtain iron sources, of the iron acquisition genes encoded in A.
actinomycetemcomitans genome, A. actinomycetemcomitans differentially expresses

genes according to what environment it is in and what different iron sources it is exposed
to.
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CHAPTER FOUR: SUMMARY AND FUTURE DIRECTIONS

Iron is the most abundant metal in nature, and as such plays a major role in many
life processes of all organisms. In the human host, iron is highly regulated, creating a
bacteriostatic environment. However in order for organisms to survive they must be able
to overcome this iron limitation by encoding in their genome iron aquisition systems.
Research to date has revealed that A. actinomycetemcomitans has encoded in its genome
at least 15 iron aquisition systems to overcome this bacteriostatic environment (67). The
iron acquisition systems enoded in A. actinomycetemcomitans are tailored towards the
specific survival strategies needed to survive in the oral biofilm. Thus A.
actinomycetemcomitans is expected to be able to utilize inorganic and organic as well as

ferric and ferrous iron sources both in planktonic culture and biofilms. These particular
findings were expected due to the redundancy of ferric iron transporters in A.
actinomycetemcomitans

genome,

and

the

particular

Iron

sources

that

A.

actinomycetemcomitans encounters in the oral cavity. In this study, we investigated the

planktonic growth of A. actinomycetemcomtians in an iron-limited and iron-chelated
environment as well as analyze the ability of A. actinomycetemcomitans to grow in an
iron-chelated environment supplemented with different iron sources and investigate what
particular iron aquistion genes are being upregulated in an iron chelated environment.
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We discovered that A. actinomycetemcomtians is capable of growing in an iron
limited environment, that though there wasn't a external iron source added to the media
that A. actinomycetemcomitans was able to scavage trace amounts of iron from other
chemicals

III

the

CDM,

and

efficiently

use

it

for

growth.

However

A.

actinomycetemcomitans was not capable of growing in an iron chelated environment. By

the second passage in an iron chelated environment A. actinomycetemcomitans growth
was drastically reduced. This lead us to the conclusion that A. actinomycetemcomitans
has an excellent internal iron storage system that the bacteria is capable of using for
growth during the first passage of growth but is not large enough to use for growth during
the second passage. The reduction of growth of the bacteria in an iron-chelated
environment occurred in a dose dependent manner.
Growth of A. actinomycetemcomitans utilizing 250 uM of ferric citrate, ferric
chloride, and hemin respectively with 150 uM DIP restored growth to the levels above
the 1sl passage in an iron chelated environment. Growth of A. actinomycetemcomitans
was higher in an hemin iron environment, suggesting that A. actinomycetemcomitans
prefers hemin as an iron source. However A. actinomycetemcomitans growth in a ferrous
sulfate iron source was very low. It was very similar to the amount of growth that was
witnessed in the 2nd passage in an iron-chelated environment leading us to the conclusion
that A. actinomycetemcomitans appears to not to be able to utilize ferrous sulfate as
effectively for growth. This was not suprising considering the analysis of A.
actinomycetemcomitans genome did not reveal in iron acquisition genes for ferrous iron

sources. However we thought that because A actinomycetemcomitans is an anaerobic
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bacteria, that in an anerobic environment that A. actinomycetemcomitans may be able to
utilize the non oxidized ferrous iron source.
Results from Realtime PCR showed that in an iron chelated environment, iron
uptake genes of A. actinomycetemcomitans are differentially regulated. Using the 1st
passage as a starting point presented as a potential limitation. CDM regular, media
containing an iron source, should have been baseline and as we started to starve the
bacteria we could have witnessed differential regulation in gene expression. Real time
PCR results were normalized to the 2nd passage and what was seen was afuA 1642
showed a 7 fold increase than in the 1st passage compared to the 2nd passage. AfuA 0696
showed a 10 fold higher increase than in the 2nd passage that in the 1st passage. While
cells are starving, there seems to be an upregulation of afuA 0696 and fecB 0795, and
iron (III) ABC transporter, and a iron (III) dicitrate binding protein (scavenging system)
respectively. The gene regulation offtnA2120 essentially stayed the same in the first and
the second passage. This makes sense that ftnA2120 is not being regulated at all
considering it is essentially and iron storage molecule. There was a down regulation of
the hemoglobin binding protein and afuABC 0696. What is interesting is that there are
three different afuA annotated gene clusters in A. actinomycetemcomitans, and all three
have different sequences. This may suggests that these genes may differentially expressed
may have different functions, and may be expressed under different conditions.
Though many questions have had some light shed on them during my research,
more research still needs to be done. Ultimately the original idea of my research was to
first look at the expression of a couple of these iron acquisition systems under the initial
iron conditions used, in other words the 1st and 2nd passages in CDM No Iron with 150
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uM DIP. After the expression of the iron acquisition genes were established under the
iron chelated conditions, our goal then was to add back specific iron sources and see what
happened to gene expression with the different iron operons under these different iron
conditions. The first part of our goal we accomplished, however the second part is a
project that a future student will carryon. I also only focused on a limited numbers of
operons, in the future more iron acquisition genes should be included. Also to make my
research show more validity, mutant strains of A. actinomycetemcomitans should be
formulated, knocking out specific iron operons and testing the growth and gene
regulation under the different iron conditions. Because past and current research all
describe A. actinomycetemcomitans as growing in a biofilm, more studies on iron
aqusition genes with A. actinomycetemcomitans grown in a biofilm formation are needed
if there are any hopes in formulating a chelator that is strong enough to chelate the
preferred iron source of A. actinomycetemcomitans, that the human host is also able to
tolerate.
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